{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:37:47Z","timestamp":1768037867778,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00702-5","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:12:12Z","timestamp":1650280332000},"page":"477-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-9191","authenticated-orcid":false,"given":"Reika Ikegami","family":"Mochizuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ikenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Kuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"702_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13443","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2021. https:\/\/doi.org\/10.1111\/imm.13443.","journal-title":"Immunology"},{"key":"702_CR2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.06.004","author":"AS Bomback","year":"2021","unstructured":"Bomback AS, Kudose S, D'Agati VD. De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far? Am J Kidney Dis. 2021. https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.004.","journal-title":"Am J Kidney Dis"},{"key":"702_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10157-021-02157-x","volume":"26","author":"K Matsuzaki","year":"2022","unstructured":"Matsuzaki K, Aoki R, Nihei Y, Suzuki H, Kihara M, Yokoo T, et al. Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan. Clin Exp Nephrol. 2022;26:316\u201322. https:\/\/doi.org\/10.1007\/s10157-021-02157-x.","journal-title":"Clin Exp Nephrol"},{"key":"702_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","volume":"100","author":"VD D'Agati","year":"2021","unstructured":"D\u2019Agati VD, Kudose S, Bomback AS, Adamidis A, Tartini A. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int. 2021;100:461\u20133. https:\/\/doi.org\/10.1016\/j.kint.2021.04.035.","journal-title":"Kidney Int"},{"key":"702_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.05.006","author":"H Komaba","year":"2021","unstructured":"Komaba H, Wada T, Fukagawa M. Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021. https:\/\/doi.org\/10.1053\/j.ajkd.2021.05.006.","journal-title":"Am J Kidney Dis"},{"key":"702_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.07.017","author":"F Salem","year":"2021","unstructured":"Salem F, Rein J, Mon-Wei YuS, Abramson M, Cravedi P, Chung M. Report of three cases of minimal change disease following the second dose of mRNA SARS-CoV-2 vaccine. Kidney Int Rep. 2021. https:\/\/doi.org\/10.1016\/j.ekir.2021.07.017.","journal-title":"Kidney Int Rep"},{"key":"702_CR7","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N Engl J Med. 2020;383:1920\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2022483.","journal-title":"N Engl J Med"},{"key":"702_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"key":"702_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40620-021-01091-1","volume":"34","author":"N Mancianti","year":"2021","unstructured":"Mancianti N, Guarnieri A, Tripodi S, Salvo DP, Garosi G. Minimal change disease following vaccination for SARS-CoV-2. J Nephrol. 2021;34:1039\u201340. https:\/\/doi.org\/10.1007\/s40620-021-01091-1.","journal-title":"J Nephrol"},{"key":"702_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15125","author":"D Steensels","year":"2021","unstructured":"Steensels D, Pierlet N, Penders J, Mesotten D, Heylen L. Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273. JAMA. 2021. https:\/\/doi.org\/10.1001\/jama.2021.15125.","journal-title":"JAMA"},{"key":"702_CR11","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, O\u2019Connell S, McDermott AB, Flach B, et al. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. N Engl J Med. 2021;384:2259\u201361. https:\/\/doi.org\/10.1056\/NEJMc2103916.","journal-title":"N Engl J Med"},{"key":"702_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.15.21262067","author":"DH Canaday","year":"2021","unstructured":"Canaday DH, Oyebanji OA, Keresztesy D, Payne M, Wilk D, Carias L, et al. Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination. Center Innov Long-Term Serv Supp. 2021. https:\/\/doi.org\/10.1101\/2021.08.15.21262067.","journal-title":"Center Innov Long-Term Serv Supp"},{"key":"702_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332\u201345. https:\/\/doi.org\/10.2215\/CJN.05000516.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00702-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T20:46:34Z","timestamp":1667335594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00702-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00702-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from the patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}